一个结构引导的抗体检测不同ALS基因型中的SOD1寡合体
Smriti Sangwan1,2, Hannah E Rieder2, Destaye Moore2
1UCLA-DOE and Molecular Biology Institutes, Department of Biological Chemistry Los Angeles, California, USA.
bioRxiv : the preprint server for biology
|July 14, 2025
概括
研究人员开发了一种新型抗体,针对有毒的超氧化解突变酶1 (SOD1) 寡合体,这对于了解肌缩侧面硬化症 (ALS) 至关重要. 这种抗体检测到这些有害的寡合体,并显示出潜在的治疗益处.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 蛋白质生物化学 蛋白质生物化学
背景情况:
- 抗体是针对特定蛋白质构成的宝贵工具.
- 开发针对粉样蛋白寡合体等短暂蛋白质结构的抗体是具有挑战性的.
- 超氧化脱酶1 (SOD1) 中的突变与家族性肌缩侧面硬化症 (fALS) 有关.
研究的目的:
- 为了产生特定于有毒SOD1寡合体的结构导向单克隆抗体.
- 在ALS的细胞模型中描述抗体的特异性及其治疗潜力.
- 在人类ALS患者组织中调查SOD1寡合物的存在.
主要方法:
- 结构引导的抗体生成针对SOD1寡合体.
- 测试以确定对SOD1寡合体,纤维和原生SOD1.1的抗体特异性.
- 使用初级运动神经元进行细胞培养实验,以评估抗体对SOD1寡合体细胞毒性的影响.
- 人类ALS患者样本的免疫组织化学分析.
主要成果:
- 产生了一个单克隆抗体,CSAb,专门检测SOD1寡合体.
- CSAb不会与SOD1纤维或原生SOD1.1结合.
- 在运动神经元中,CSAb减轻了SOD1寡合体的细胞毒性作用.
- 在人类ALS患者的神经元和非神经元细胞中发现了CSAb反应性SOD1寡合体.
- 这些反应性SOD1寡合体存在于各种ALS基因型中,包括非SOD1相关的fALS和零星ALS.
结论:
- CSAb是一种用于检测细胞毒性SOD1寡合体的新型和特定探针.
- 细胞毒性SOD1寡合体与以前认为的更广泛的ALS病例有关.
- 这种抗体为ALS研究提供了一个新的工具,以及针对SOD1寡合体病理的潜在治疗策略.
更多相关视频
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
8.9K
11:12Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
Published on: October 4, 2017
7.3K
相关概念视频
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:25Antibody Structure and Classes
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.